Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
Mapato ya Q1 2026 • baada ya siku 3
Angalia maelezo
AMG:ETR
Amgen Inc
€ 293.25
-0.31%
(-0.90) Siku 1
27 Apr, 17:35:39 GMT +2  ·   EUR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya AMG...
Fungua
€ 295.25
Juu
€ 295.25
Chini
€ 291.00
Mtaji wa soko
183.57B
Wastani wa kiasi cha mauzo
304.00
Kiasi cha mauzo ya hisa
448.00
Juu kwa wiki 52
€ 333.00
Chini kwa wiki 52
€ 230.00
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000. Wikipedia
Kuhusu Amgen Inc
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa8 Apr 1980
Makao makuuThousand Oaks, California, Marekani
Sekta-
Tovutiamgen.com
Simu inayofuata baada ya siku baada ya siku 3
Alhamisi, 30 Apr, 16:30
Kipindi cha Kifedha
Robo1 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
-/ (4.77 inakadiriwa)USD
Mapato au Kadirio
-/ (8.57B inakadiriwa)USD
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari: mapato yajayoMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
8.15B
9.18B
9.56B
9.87B
Gharama ya bidhaa zilizouzwa
2.60B
2.67B
2.74B
2.68B
Gharama ya mapato
2.60B
2.67B
2.74B
2.68B
Gharama za utafiti na maendeleo
1.49B
1.74B
1.90B
2.14B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.69B
1.69B
1.72B
1.95B
Gharama ya uendeshaji
3.20B
3.50B
3.55B
4.18B
Jumla ya gharama za uendeshaji
5.81B
6.18B
6.29B
6.85B
Mapato ya uendeshaji
2.34B
3.00B
3.26B
3.01B
Mapato mengine yasiyo ya uendeshaji
-36.00M
-113.00M
181.00M
143.00M
EBT ikijumuisha vipengee visivyo vya kawaida
1.97B
1.57B
3.92B
1.51B
EBT bila kujumuisha vipengee visivyo vya kawaida
1.66B
2.37B
2.72B
2.51B
Gharama ya kodi ya mapato
243.00M
136.00M
705.00M
181.00M
Kiwango cha kodi kinachotumika
12.32%
8.67%
17.98%
11.96%
Gharama nyingine za uendeshaji
30.00M
68.00M
-71.00M
82.00M
Mapato halisi
1.73B
1.43B
3.22B
1.33B
Kiwango cha faida halisi
21.23%
15.60%
33.65%
13.51%
Mapato kwa kila hisa
4.90
6.02
5.64
5.29
Mapato ya riba na uwekezaji
-
-
-
408.00M
Gharama ya riba
-723.00M
-694.00M
-685.00M
-1.06B
Jumla ya gharama halisi za riba
-723.00M
-694.00M
-685.00M
-653.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
3.73B
4.34B
4.57B
4.02B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho